8-K//Current report
Quince Therapeutics, Inc. 8-K
Accession 0000950170-25-106536
$QNCXCIK 0001662774operating
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:05 PM ET
Size
456.9 KB
Accession
0000950170-25-106536
Documents
- 8-Kqncx-20250811.htmPrimary
8-K
- EX-99.1qncx-ex99_1.htm
EX-99.1
- EX-101.SCHqncx-20250811.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-106536-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLqncx-20250811_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001662774
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:05 PM ET
- Size
- 456.9 KB